Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by DJDawgon May 25, 2024 7:24pm
251 Views
Post# 36057647

RE:RE:RE:New patients coming

RE:RE:RE:New patients coming
I could be wrong but the way clinics work is that the MDs are always behind and often pick the easiest path in front of them. Most studies I have been part of got very low recruitement unless the company sent in someone to make it happen. BTW the easiest path is to just sign them up for never ending gem/doc or a nother round of BCG if you have it. Or just tell the patient to go to cystectomy. Most centres have many studies on the go (in this case it would be prostate studies, LR-NIMBC, renal studies, testicular cancer studies etc). It is hard to keep track of it all sometimes.

I hope I'm wrong but my suspicion is that they have not had the funds to put boots on the ground at the sites while the competitors like CGON have big pockets for that sort of thing. Not that they are recruiting at the same sites. I think most centres only recruit for one study at a time for a particular indications.
<< Previous
Bullboard Posts
Next >>